col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


27 Results       Page 1

 [1] 
Informa UK (Taylor & Francis): mAbs
  original article Date Title Authors   All Authors
1 [GO] 2025―Mar―01 Prediction of long-term stability of high-concentration formulations to support rapid development of antibodies against SARS-CoV-2 Lin Luo, Michael Meleties, Julie Beaudet, Yuan Cao, Wenhua Wang, Qingyan Hu, et al. (+4)
2 [GO] 2024―Apr―09 Enrichment strategy and initial characterization of heterodimers enriched from a co-formulated cocktail of therapeutic antibodies against SARS-COV-2 Sophia Liu, Yuetian Yan, Cody M. Secor, Zachary R. Oberholtzer, Donna J. Skow, Mushhood Sheikh, et al. (+8)
3 [GO] 2023―Jun―06 Effects of the COVID-19 pandemic: new approaches for accelerated delivery of gene to first-in-human CMC data for recombinant proteins Hervé Broly, Jonathan Souquet, Alain Beck
4 [GO] 2023―May―25 Multivalent IgM scaffold enhances the therapeutic potential of variant-agnostic ACE2 decoys against SARS-CoV-2 Meghan M. Verstraete, Florian Heinkel, Janessa Li, Siran Cao, Anh Tran, Elizabeth C. Halverson, et al. (+14)
5 [GO] 2022―Dec―08 Developability profiling of a panel of Fc engineered SARS-CoV-2 neutralizing antibodies Andrew Dippel, Austin Gallegos, Vineela Aleti, Arnita Barnes, Xiaoru Chen, Elizabeth Christian, et al. (+26)
6 [GO] 2022―Oct―18 Pandemic’s silver lining Fortunato Ferrara, Sara D’Angelo, M. Frank Erasmus, André A. Teixeira, Camila Leal-Lopes, Laura P. Spector, et al. (+4)
7 [GO] 2022―May―20 Deep mutational engineering of broadly-neutralizing nanobodies accommodating SARS-CoV-1 and 2 antigenic drift Adrien Laroche, Maria Lucia Orsini Delgado, Benjamin Chalopin, Philippe Cuniasse, Steven Dubois, Raphaël Sierocki, et al. (+6)
8 [GO] 2022―May―11 Novel super-neutralizing antibody UT28K is capable of protecting against infection from a wide variety of SARS-CoV-2 variants Tatsuhiko Ozawa, Hideki Tani, Yuki Anraku, Shunsuke Kita, Emiko Igarashi, Yumiko Saga, et al. (+18)
9 [GO] 2022―Apr―05 David versus goliath: ACE2-Fc receptor traps as potential SARS-CoV-2 inhibitors Mohamed A. Alfaleh, Ayat Zawawi, Sawsan S. Al-Amri, Anwar M. Hashem
10 [GO] 2022―Apr―05 Upstream cell culture process characterization and in-process control strategy development at pandemic speed Jianlin Xu, Jianfa Ou, Kyle P. McHugh, Michael C. Borys, Anurag Khetan
11 [GO] 2022―Mar―16 Comprehensive engineering of a therapeutic neutralizing antibody targeting SARS-CoV-2 spike protein to neutralize escape variants Taichi Kuramochi, Siok Wan Gan, Adrian W.S. Ho, Bei Wang, Nagisa Kageji, Takeru Nambu, et al. (+11)
12 [GO] 2022―Mar―15 Nebulized delivery of a broadly neutralizing SARS-CoV-2 RBD-specific nanobody prevents clinical, virological, and pathological disease in a Syrian hamster model of COVID-19 Thomas J. Esparza, Yaozong Chen, Negin P. Martin, Helle Bielefeldt-Ohmann, Richard A. Bowen, William D. Tolbert, et al. (+2)
13 [GO] 2022―Feb―27 Therapeutic antibodies for COVID-19: is a new age of IgM, IgA and bispecific antibodies coming? Jingjing Zhang, Han Zhang, Litao Sun
14 [GO] 2022―Jan―15 Computational design of a neutralizing antibody with picomolar binding affinity for all concerning SARS-CoV-2 variants Bo-Seong Jeong, Jeong Seok Cha, Insu Hwang, Uijin Kim, Jared Adolf-Bryfogle, Brian Coventry, et al. (+3)
15 [GO] 2021―Dec―30 Rapid discovery of diverse neutralizing SARS-CoV-2 antibodies from large-scale synthetic phage libraries Tom Z. Yuan, Pankaj Garg, Linya Wang, Jordan R. Willis, Eric Kwan, Ana G Lujan Hernandez, et al. (+17)
16 [GO] 2021―Dec―20 Quality comparability assessment of a SARS-CoV-2-neutralizing antibody across transient, mini-pool-derived and single-clone CHO cells Gangling Xu, Chuanfei Yu, Wenbo Wang, Cexiong Fu, Hongchuan Liu, Yanping Zhu, et al. (+13)
17 [GO] 2021―Oct―25 Bifunctional molecules targeting SARS-CoV-2 spike and the polymeric Ig receptor display neutralization activity and mucosal enrichment Ian White, Ninkka Tamot, Rajitha Doddareddy, Jason Ho, Qun Jiao, Paul B. Harvilla, et al. (+7)
18 [GO] 2021―Aug―04 Development of potent and effective synthetic SARS-CoV-2 neutralizing nanobodies Maxwell A. Stefan, Yooli K. Light, Jennifer L. Schwedler, Peter R. McIlroy, Colleen M. Courtney, Edwin A. Saada, et al. (+10)
19 [GO] 2021―Jul―27 Characterization of MW06, a human monoclonal antibody with cross-neutralization activity against both SARS-CoV-2 and SARS-CoV Wen Jiang, Junchao Wang, Shasha Jiao, Chenjian Gu, Wei Xu, Ben Chen, et al. (+11)
20 [GO] 2021―Jun―07 A human antibody of potent efficacy against SARS-CoV-2 in rhesus macaques showed strong blocking activity to B.1.351 Chunyin Gu, Xiaodan Cao, Zongda Wang, Xue Hu, Yanfeng Yao, Yiwu Zhou, et al. (+39)
21 [GO] 2021―Jun―02 501Y.V2 and 501Y.V3 variants of SARS-CoV-2 lose binding to bamlanivimab in vitro Haolin Liu, Pengcheng Wei, Qianqian Zhang, Zhongzhou Chen, Katja Aviszus, Walter Downing, et al. (+7)
22 [GO] 2021―May―24 Potent SARS-CoV-2 binding and neutralization through maturation of iconic SARS-CoV-1 antibodies Romain Rouet, Ohan Mazigi, Gregory J. Walker, David B. Langley, Meghna Sobti, Peter Schofield, et al. (+14)
23 [GO] 2021―Apr―12 Rigid monoclonal antibodies improve detection of SARS-CoV-2 nucleocapsid protein Curtis D. Hodge, Daniel. J. Rosenberg, Patricia Grob, Mateusz Wilamowski, Andrzej Joachimiak, Greg L. Hura, Michal Hammel
24 [GO] 2021―Mar―05 Bispecific VH/Fab antibodies targeting neutralizing and non-neutralizing Spike epitopes demonstrate enhanced potency against SARS-CoV-2 Shion A. Lim, Josef A. Gramespacher, Katarina Pance, Nicholas J. Rettko, Paige Solomon, Jing Jin, et al. (+8)
25 [GO] 2020―Aug―19 A novel biparatopic hybrid antibody-ACE2 fusion that blocks SARS-CoV-2 infection: implications for therapy Xiaoniu Miao, Yi Luo, Xi Huang, Suki M. Y. Lee, Zhijun Yuan, Yongzhou Tang, et al. (+23)
26 [GO] 2020―Jun―17 Ig-like ACE2 protein therapeutics: A revival in development during the COVID-19 pandemic Kewen Qian, Shi Hu
27 [GO] 2020―Jun―16 Potent neutralization of SARS-CoV-2 by human antibody heavy-chain variable domains isolated from a large library with a new stable scaffold Zehua Sun, Chuan Chen, Wei Li, David R. Martinez, Aleksandra Drelich, Du-San Baek, et al. (+5)
 [1] 

27 Results       Page 1


[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.005 sec